| BioID | bio200604 |
|---|
| Name | REPAGLINIDE |
|---|
| ChEMBL ID | CHEMBL1272 |
|---|
| Molecular Formula | C27H36N2O4 |
|---|
| Molecular Weight | 452.6 |
|---|
| Molecular Weight (Monoisotopic) | 452.2675 |
|---|
| Type | Small molecule |
|---|
| Max Phase | Phase 4 |
|---|
| Target ID | Tar81 |
|---|
| Target Name | None |
|---|
| Synonyms | A10BX02|AG-EE 623 ZW|AG-EE-623-ZW|AG-EE-623ZW|AGEE-623ZW|ENYGLID|NOVONORM|NSC-759893|PRANDIN|Prandin|REPAGLINIDA|REPAGLINIDE|Repaglinide Krka |
|---|
| Smiles | CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O |
|---|
| Inchi | InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1 |
|---|
| Inchi Key | FAEKWTJYAYMJKF-QHCPKHFHSA-N |
|---|
| Molecular Species | ACID |
|---|
| Targets | 125.0 |
|---|
| Bioactivities | 438.0 |
|---|
| Np Likeness Score | -0.79 |
|---|
| Records Key | ['repaglinide', 'SID11112894', '(S)-6al', 'repaglinide', 'repaglinide', '296', '199, repaglinide', 'repaglinide', '18', 'REPAGLINIDE', 'Repaglinide', 'REPAGLINIDE', 'SID49648522', 'SID144204272', 'Repaglinide', 'repaglinide', 'Repaglinide', 'SID26719812', 'Repaglinide', 'REPAGLINIDE', 'REPAGLINIDE', 'REPAGLINIDE', 'M0', 'Repaglinide', 'Repaglinide', 'Repaglinide', 'repaglinide', 'REPAGLINIDE', 'Repaglinide', 'repaglinide', 'Repaglinide', '12', 'REPAGLINIDE', 'REPAGLINIDE', 'REPAGLINIDE', '3630', 'repaglinide', 'SAM001246546', 'Repaglinide', 'Repaglinide', 'Repaglinide', 'Repaglinide', 'REPAGLINIDE', 'REPAGLINIDE', 'REPAGLINIDE', 'COVC-3357844292', 'Repaglinide', 'REPAGLINIDE', 'repaglinide', 'EUB0001802a', 'EUB0001802a', 'BA1000972'] |
|---|
| Records Name | ['2-Ethoxy-4-{[(S)-3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid', 'SID11112894', '2-Ethoxy-4-{[(S)-3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid', 'repaglinide', 'repaglinide', 'Repaglinide', '(S)-2-ethoxy-4-(2-(3-methyl-1-(2-(piperidin-1-yl)phenyl)butylamino)-2-oxoethyl)benzoic acid', 'repaglinide', 'Repaglinide', 'REPAGLINIDE', 'Repaglinide', 'REPAGLINIDE', 'SID49648522', 'SID144204272', 'Repaglinide', '2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid', 'Repaglinide', 'SID26719812', 'Repaglinide', 'REPAGLINIDE', 'REPAGLINIDE', 'REPAGLINIDE', 'Repaglinide', 'Repaglinide', 'Repaglinide', 'Repaglinide', 'repaglinide', 'REPAGLINIDE', 'Repaglinide', 'repaglinide', 'Repaglinide', 'Repaglinide', 'REPAGLINIDE', 'REPAGLINIDE', 'REPAGLINIDE', None, 'repaglinide', 'C0164572', 'Repaglinide', 'Repaglinide', 'Repaglinide', 'Repaglinide', 'REPAGLINIDE', 'REPAGLINIDE', 'REPAGLINIDE', 'REPAGLINIDE', 'Repaglinide', 'REPAGLINIDE', 'repaglinide', 'Repaglinide', 'Repaglinide', 'REPAGLINIDE'] |
|---|
| Withdrawn Flag | False |
|---|
| Orphan | 0 |
|---|
